Search

“We are in a very interesting period in which poor economic data is actually viewed somewhat favorably by equity investors (as was the case following Monday’s PMI news) in that weak stats suggest that Ben Bernanke & Co. will delay the start of the tapering of its Quantitative Easing program,...

Happy Thanksgiving! I hope you are enjoying a festive day with family and friends.

Crista is adding a stock to the the Buy Low Opportunities Portfolio.

We are now living through an unprecedented time in the U.S., and in the world at large, when institutions, schools, universities and more are being shut down from public attendance so as to curtail the spread of a virus named COVID-19.

While the broad market enjoyed a powerful upmove yesterday, the marijuana sector was even stronger, with the Marijuana Index surging 15%.

Three of our portfolio stocks reported earnings this week.

Cabot explains how the Dow could reach 14,000 in 2011.

We’ve been enjoying a crazy-strong market in many growth stocks lately, which has padded our paper gains in many of those positions. Today we’re going to step off the gas a little, book a few modest profits and step aside from some positions that haven’t done a lot lately.

Arcosa (ACA) released an uninspiring report on Wednesday that was particularly ill-timed given yesterday’s market retreat. The company missed across the board. Revenue was up 2.7% to $459 million, missing by $4.7 million while adjusted EPS of $0.33 missed by $0.08. Guidance for 2021 also missed.

MarketWatch reports that Cabot Market Letter owes its strong performance in 2007 to market timing and stock selection.

AgFeed Industries is a Chinese company that sells pre-mixed food for livestock, especially pigs, to the enormous Chinese market.

Using position sizing and offensive selling to reduce growth stock investing risk.

After weeks on the upside, the market has finally hit a bit of a pothole over the past few days, with some up-down-up-down action coming since Wednesday. The action isn’t a total shock given the elevated sentiment and the fact that most stocks are stretched to the upside.

Buying the dip has paid off handsomely for investors for years, but with the current meltdown, you should wait for the dust to settle.

With ongoing state-level developments and marijuana stocks trading at some of their lowest levels ever, there’s a contrarian case for averaging into cannabis stocks.

With a new year on the horizon, we’re making three bold predictions about what 2024 has in store for cannabis investors.

Cannabis investors need to practice patience while they wait for the next major sector catalyst, but they’re on the horizon on both the state and federal levels.

The performance of Rolls Royce (RYCEY) stock has been phenomenal this year, but an ongoing development in their New Markets segment could offer more room to run.

Value investors have a wide variety of tools at their disposal, and estimate revisions are one way they can avoid value traps.